Patents by Inventor Stephen M. Berge

Stephen M. Berge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sustained-released product comprising a combination of a non-opioid amine and a non-steroidal, anti-inflammatory drug
    Patent number: 9456985
    Abstract: Sustained-release oral pharmaceutical compositions and methods of use, wherein the compositions are in a single dosage form and include an amine-containing compound (including salts thereof), a salt of a non-steroidal anti-inflammatory drug (NSAID), and a hydrophilic matrix.
    Type: Grant
    Filed: April 28, 2015
    Date of Patent: October 4, 2016
    Assignee: UPSHER-SMITH LABORATORIES, INC.
    Inventors: Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Sean B. Mahoney, Stephen M. Berge
  • Sustained-Released Product Comprising a Combination of a Non-Opioid Amine and a Non-Steroidal, Anti-Inflammatory Drug
    Publication number: 20150238423
    Abstract: Sustained-release oral pharmaceutical compositions and methods of use, wherein the compositions are in a single dosage form and include an amine-containing compound (including salts thereof), a salt of a non-steroidal anti-inflammatory drug (NSAID), and a hydrophilic matrix.
    Type: Application
    Filed: April 28, 2015
    Publication date: August 27, 2015
    Applicant: UPSHER-SMITH LABORATORIES, INC.
    Inventors: CHRISTIAN F. WERTZ, JAMES S. JENSEN, VICTORIA ANN O'NEILL, SEAN B. MAHONEY, STEPHEN M. BERGE
  • Opioid-Containing Oral Pharmaceutical Compositions and Methods
    Publication number: 20150182462
    Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an opioid (including salts thereof) and a salt of a non-steroidal anti-inflammatory drug (NSAID).
    Type: Application
    Filed: March 11, 2015
    Publication date: July 2, 2015
    Inventors: Kenneth L. EVENSTAD, Christian F. WERTZ, James S. JENSEN, Victoria Ann O'NEILL, Stephen M. BERGE
  • Sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti-inflammatory drug
    Patent number: 9023390
    Abstract: Sustained-release oral pharmaceutical compositions and methods of use, wherein the compositions are in a single dosage form and include an amine-containing compound (including salts thereof), a salt of a non-steroidal anti-inflammatory drug (NSAID), and a hydrophilic matrix.
    Type: Grant
    Filed: December 31, 2009
    Date of Patent: May 5, 2015
    Assignee: Upsher-Smith Laboratories, Inc.
    Inventors: Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Sean B. Mahoney, Stephen M. Berge
  • Opioid-containing oral pharmaceutical compositions and methods
    Patent number: 8987291
    Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an opioid (including salts thereof) and a salt of a non-steroidal anti-inflammatory drug (NSAID).
    Type: Grant
    Filed: December 14, 2012
    Date of Patent: March 24, 2015
    Assignee: Upsher Smith Laboratories, Inc.
    Inventors: Kenneth L. Evenstad, Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Stephen M. Berge
  • Opioid-containing oral pharmaceutical compositions and methods
    Patent number: 8362029
    Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an opioid (including salts thereof) and a salt of a non-steroidal anti-inflammatory drug (NSAID).
    Type: Grant
    Filed: December 31, 2009
    Date of Patent: January 29, 2013
    Assignee: Upsher-Smith Laboratories, Inc.
    Inventors: Kenneth L. Evenstad, Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Stephen M. Berge
  • SUSTAINED-RELEASE PRODUCT COMPRISING A COMBINATION OF A NON-OPIOID AMINE AND A NON-STERIODAL ANTI-INFLAMMATORY DRUG
    Publication number: 20120252833
    Abstract: Sustained-release oral pharmaceutical compositions and methods of use, wherein the compositions are in a single dosage form and include an amine-containing compound (including salts thereof), a salt of a non-steroidal anti-inflammatory drug (NSAID), and a hydrophilic matrix.
    Type: Application
    Filed: December 31, 2009
    Publication date: October 4, 2012
    Applicant: UPSHER-SMITH LABORATORIES, INC.
    Inventors: Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Sean B. Mahoney, Stephen M. Berge
  • OPIOID-CONTAINING ORAL PHARMACEUTICAL COMPOSITIONS AND METHODS
    Publication number: 20110275658
    Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an opioid (including salts thereof) and a salt of a non-steroidal anti-inflammatory drug (NSAID).
    Type: Application
    Filed: December 31, 2009
    Publication date: November 10, 2011
    Applicant: UPSHER-SMITH LABORATORIES, INC.
    Inventors: Kenneth L. Evenstad, Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Stephen M. Berge
  • SUSTAINED-RELEASE FORMULATIONS
    Publication number: 20100221328
    Abstract: Described herein are extended-release or sustained-release formulations suitable for highly soluble pharmacologically active compounds, for example, amantadine. Dosage units for providing extended release are provided by the present invention. In some embodiments, the dosage unit comprises a plurality of coated beads having drug layer and a coating layer, wherein the coating layer comprises an ethylcellulose polymer. In some embodiments, near zero-order release of the active compound is achieved.
    Type: Application
    Filed: December 30, 2009
    Publication date: September 2, 2010
    Inventors: Christian F. Wertz, Victoria Ann O'Neill, Stephen M. Berge
  • Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo?4,5-C!quinolin-4-amine
    Patent number: 5736553
    Abstract: Pharmaceutical formulations and adhesive-coated sheet materials for the topical and/or transdermal delivery of 1-isobutyl-1H-imidazo?4,5-c!-quinolin-4-amine, including creams, ointments and pressure-sensitive adhesive compositions. Pharmacological methods of using the formulations and the adhesive-coated sheet materials of the invention in the treatment of viral infections.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: April 7, 1998
    Assignee: Riker Laboratories, Inc.
    Inventors: Steven M. Wick, Helen Jensen Schultz, Gregory R. Nelson, Amit K. Mitra, Stephen M. Berge
  • Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
    Patent number: 5238944
    Abstract: Pharmaceutical formulations and adhesive-coated sheet materials for the topical and/or transdermal delivery of 1-isobutyl-1H-imidazo[4,5-c]-quinolin-4-amine, including creams, ointments and pressure-sensitive adhesive compositions. Pharmacological methods of using the formulations and the adhesive-coated sheet materials of the invention in the treatment of viral infections.
    Type: Grant
    Filed: March 3, 1992
    Date of Patent: August 24, 1993
    Assignee: Riker Laboratories, Inc.
    Inventors: Steven M. Wick, Helen J. Schultz, Gregory R. Nelson, Amit K. Mitra, Stephen M. Berge
  • Oral suspension formulation
    Patent number: 5112604
    Abstract: An aqueous suspension for oral administration of a drug, which suspension is storage stable for a prolonged period and maintains the drug in suspension during such period.
    Type: Grant
    Filed: September 1, 1989
    Date of Patent: May 12, 1992
    Assignee: Riker Laboratories, Inc.
    Inventors: Joseph M. Beaurline, Stephen M. Berge, Robert K. Schultz